Company Data
Prelude Therapeutics Incorporated
Ticker
PRLD
Current Price
$4.2 0.48%
Market Cap
$334.5M
Price Target
Refer to Report
Volume
180.7K
52wk Range
$0.75 - $5.69
Overview
Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need.